Income Statement (TTM)
Crescita Therapeutics Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17 | 16 | 15 | 16 | 12 | 17 | 18 | 22 | 25 | 24 | 23 | 22 | 19 | 18 | 18 | 17 | 17 | 20 | 18 | 20 |
| Change (%) | -6.17 | -3.52 | 8.06 | -26.42 | 39.76 | 10.05 | 19.31 | 13.80 | -6.11 | -1.48 | -5.82 | -13.74 | -6.93 | 2.25 | -5.99 | 3.33 | 12.51 | -7.45 | 11.84 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 4 | 4 | 5 | 5 | 7 | 8 | 9 | 11 | 10 | 10 | 9 | 8 | 7 | 8 | 8 | 8 | 10 | 9 | 10 |
| Change (%) | -10.00 | -4.63 | 14.07 | 6.23 | 33.84 | 16.14 | 20.88 | 17.15 | -6.90 | -3.61 | -7.74 | -16.96 | -6.28 | 10.04 | -3.05 | 1.22 | 29.00 | -7.97 | 6.05 | |
| % of Revenue | 29.11 | 27.92 | 27.60 | 29.14 | 42.07 | 40.28 | 42.51 | 43.07 | 44.33 | 43.97 | 43.02 | 42.14 | 40.57 | 40.85 | 43.97 | 45.34 | 44.42 | 50.93 | 50.64 | 48.02 |
| Gross Operating Profit | 12 | 11 | 11 | 12 | 7 | 10 | 11 | 13 | 14 | 13 | 13 | 13 | 11 | 10 | 10 | 9 | 10 | 10 | 9 | 11 |
| Change (%) | -4.60 | -3.09 | 5.77 | -39.84 | 44.07 | 5.95 | 18.14 | 11.27 | -5.49 | 0.18 | -4.38 | -11.40 | -7.37 | -3.14 | -8.31 | 5.08 | -0.67 | -6.91 | 17.78 | |
| % of Revenue | 70.89 | 72.08 | 72.40 | 70.86 | 57.93 | 59.72 | 57.49 | 56.93 | 55.67 | 56.03 | 56.98 | 57.86 | 59.43 | 59.15 | 56.03 | 54.66 | 55.58 | 49.07 | 49.36 | 51.98 |
| SG&A | 8 | 8 | 8 | 8 | 8 | 9 | 10 | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 10 | 10 |
| Change (%) | -2.71 | -0.31 | 4.23 | 2.11 | 14.05 | 4.59 | 7.24 | 2.10 | -2.79 | -1.49 | -1.67 | 0.72 | -1.94 | 1.48 | 0.68 | 3.00 | 0.37 | -2.45 | -0.61 | |
| % of Revenue | 48.40 | 50.18 | 51.85 | 50.01 | 69.40 | 56.63 | 53.82 | 48.38 | 43.41 | 44.94 | 44.94 | 46.92 | 54.79 | 57.73 | 57.30 | 61.36 | 61.17 | 54.57 | 57.51 | 51.11 |
| R&D | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 35.26 | -0.82 | -19.96 | -9.84 | -19.54 | -14.51 | 7.93 | 5.98 | -1.77 | 5.42 | 2.65 | -2.73 | 9.05 | 1.43 | -2.12 | 2.02 | -8.76 | -6.04 | -3.62 | |
| % of Revenue | 4.88 | 7.04 | 7.24 | 5.36 | 6.57 | 3.78 | 2.94 | 2.66 | 2.47 | 2.59 | 2.77 | 3.02 | 3.40 | 3.99 | 3.96 | 4.12 | 4.07 | 3.30 | 3.35 | 2.89 |
| OpEx | 16 | 15 | 14 | 15 | 15 | 18 | 20 | 22 | 24 | 23 | 23 | 22 | 20 | 19 | 20 | 20 | 20 | 23 | 22 | 22 |
| Change (%) | -4.64 | -2.15 | 4.39 | 2.10 | 18.28 | 8.04 | 12.26 | 8.55 | -4.37 | -2.13 | -4.11 | -6.88 | -3.08 | 4.56 | -1.26 | 1.75 | 10.78 | -4.98 | 2.40 | |
| % of Revenue | 93.15 | 94.67 | 96.02 | 92.76 | 128.70 | 108.92 | 106.93 | 100.61 | 95.97 | 97.75 | 97.11 | 98.89 | 106.75 | 111.16 | 113.68 | 119.41 | 117.58 | 115.77 | 118.87 | 108.84 |
| Operating Income | 1 | 1 | 1 | 1 | -3 | -1 | -1 | -0 | 1 | 1 | 1 | 0 | -1 | -2 | -2 | -3 | -3 | -3 | -3 | -2 |
| Change (%) | -26.99 | -27.85 | 96.51 | -391.62 | -56.56 | -14.51 | -89.44 | -848.89 | -47.68 | 26.47 | -63.68 | -623.05 | 53.89 | 25.31 | 33.37 | -6.39 | 0.92 | 10.72 | -47.59 | |
| % of Revenue | 6.85 | 5.33 | 3.98 | 7.24 | -28.70 | -8.92 | -6.93 | -0.61 | 4.03 | 2.25 | 2.89 | 1.11 | -6.75 | -11.16 | -13.68 | -19.41 | -17.58 | -15.77 | -18.87 | -8.84 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -39.71 | -17.46 | 3.85 | 5.09 | 3.96 | 5.51 | -6.02 | -16.24 | -19.39 | -24.05 | -22.50 | -4.30 | -4.49 | -5.88 | -5.00 | -7.89 | -7.14 | -9.23 | -8.47 | |
| % of Revenue | -2.51 | -1.61 | -1.38 | -1.32 | -1.89 | -1.41 | -1.35 | -1.06 | -0.78 | -0.67 | -0.52 | -0.43 | -0.47 | -0.49 | -0.45 | -0.45 | -0.40 | -0.33 | -0.33 | -0.27 |
| Net Income | 0 | 0 | 0 | 2 | -3 | -1 | -1 | -0 | 1 | 1 | 1 | 1 | -1 | -2 | -2 | -3 | -3 | -3 | -3 | -1 |
| Change (%) | -74.66 | 156.76 | 2,497.89 | -206.97 | -58.14 | 3.44 | -59.06 | -233.97 | 37.48 | 23.32 | -22.95 | -180.34 | 201.82 | 17.77 | 27.58 | -8.24 | 0.44 | 11.13 | -56.41 | |
| % of Revenue | 0.88 | 0.24 | 0.63 | 15.14 | -22.00 | -6.59 | -6.19 | -2.13 | 2.50 | 3.66 | 4.59 | 3.75 | -3.49 | -11.33 | -13.06 | -17.72 | -15.73 | -14.04 | -16.86 | -6.57 |
Source: Capital IQ
